No Association of TPH1 218A/C Polymorphism with Treatment Response and Intolerance to SSRIs in Japanese Patients with Major Depression

Publisher： Karger

E-ISSN： 1423-0224|56|4|167-171

ISSN： 0302-282x

Source： Neuropsychobiology, Vol.56, Iss.4, 2008-03, pp. : 167-171

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Serotonin-Related Polymorphisms in TPH1 and HTR5A Genes Are Not Associated with Escitalopram Treatment Response in Korean Patients with Major Depression

By  

Neuropsychobiology, Vol. 69, Iss. 4, 2014-05 ,pp. : 210-219

Karger

Access to resources Recommend Favorite

Bcl1 Polymorphism of the Glucocorticoid Receptor Gene and Treatment Response to Milnacipran and Fluvoxamine in Japanese Patients with Depression

By  

Neuropsychobiology, Vol. 70, Iss. 3, 2014-10 ,pp. : 173-180

Karger

Access to resources Recommend Favorite

TPH1, MAOA, Serotonin Receptor 2A and 2C Genes in Citalopram Response: Possible Effect in Melancholic and Psychotic Depression

By  

Neuropsychobiology, Vol. 67, Iss. 1, 2012-12 ,pp. : 41-47

Karger

Access to resources Recommend Favorite

Association between -1438G/A Promoter Polymorphism in the 5-HT2A Receptor Gene and Fluvoxamine Response in Japanese Patients with Major Depressive Disorder

By  

Neuropsychobiology, Vol. 46, Iss. 3, 2002-11 ,pp. : 136-140

Karger

Access to resources Recommend Favorite

Clinical Features and Treatment Response of Patients with Major Depression and Silent Cerebral Infarction

By  

Neuropsychobiology, Vol. 44, Iss. 4, 2001-11 ,pp. : 176-182

Karger

Access to resources Recommend Favorite